Quebec Pharmacists Gain Major New Prescribing and Renewal Powers, Effective December 9

The Ordre des pharmaciens du Quebec (OPQ) announced August 20, 2026 that pharmacists in the province will gain a significantly expanded scope of professional practice effective December 9, 2026, covering prescribing, prescription renewal, drug substitution and medication administration. Quebec's Ministry of Health confirmed the announcement the same day.

Key takeaways

• Pharmacists will be able to perform throat swabs to detect streptococcus and prescribe treatment when indicated.
• Pharmacists can independently modify a patient's medication if it is causing an adverse reaction, without waiting for the prescriber.
• Prescriptions for an already-diagnosed chronic disease can be extended or renewed without the previous limits.
• Pharmacists gain broader authority to prescribe for common, minor health problems.

Why this matters

"Pharmacists are accessible healthcare professionals present throughout Quebec's regions," OPQ president Jean-Francois Desgagne said, adding that the new activities will let pharmacists "exercise their full knowledge and competencies for public benefit." The OPQ was explicit that the rollout will be gradual and uneven across the province: real-world use of the new powers depends on each pharmacist's clinical judgment, patient assessment, available patient information, applicable regulations, and a pharmacy's capacity for proper follow-up -- an implicit nod to Quebec's ongoing pharmacy-technician staffing shortage.

The OPQ also noted it continues working with Quebec's Office des professions on separate regulations that would grant pharmacists holding an advanced pharmacotherapy master's degree even broader independent prescribing authority.

Practice guidance for pharmacists

• Confirm your pharmacy has the technician and workflow capacity for proper follow-up before offering a new activity broadly -- the OPQ has flagged this as a real constraint, not a formality.
• Review the OPQ's detailed practice guidance for each new activity (throat swabs, medication adjustment for adverse reactions, chronic-disease renewals) before December 9, since scope varies by activity and patient situation.
• Document the clinical reasoning behind an independent medication adjustment as thoroughly as a new prescription, since this is an unsupervised prescribing decision.
• Watch for the separate advanced-pharmacotherapy-master's regulation still under development with the Office des professions, which would extend authority further for pharmacists with that credential.
• Expect uneven rollout across pharmacies and regions in the early months -- the OPQ has said this explicitly, so patients may need to be redirected to a participating pharmacy for some services.

What's next

The expanded scope takes effect December 9, 2026. Pharmacists should watch for OPQ practice guidance updates and confirmation of the separate advanced-pharmacotherapy prescribing regulation as it moves through the Office des professions.